
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/3-MeO-PCP: Difference between revisions
Jump to navigation
Jump to search
>Unity No edit summary |
>Unity No edit summary |
||
Line 35: | Line 35: | ||
|MolecularStructureCaption= | |MolecularStructureCaption= | ||
|SkeletalImageFile=File:3-MeO-PCP.png | |SkeletalImageFile=File:3-MeO-PCP.png | ||
|SkeletalImageWidth= | |SkeletalImageWidth=245px | ||
|3DImageFile= | |3DImageFile= | ||
|3DImageWidth= | |3DImageWidth= | ||
<!-- Nomenclature --> | <!-- Nomenclature --> | ||
|NameCommon=3-MeO-PCP | |NameCommon=3-MeO-PCP, Methoxyphencyclidine | ||
|NameSubstitution=3-Methoxyphencyclidine | |NameSubstitution=3-Methoxyphencyclidine | ||
|NameSystematic=1-[1-(3-methoxyphenyl)cyclohexyl]-piperidine | |NameSystematic=1-[1-(3-methoxyphenyl)cyclohexyl]-piperidine | ||
Line 55: | Line 55: | ||
|OralROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. <u>[[responsible drug use|See responsible use section]].</u><br> '''[[Disclaimer|DISCLAIMER]]:''' PW's [[dosage]] information is gathered from users and [[Network|resources]] for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy. | |OralROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. <u>[[responsible drug use|See responsible use section]].</u><br> '''[[Disclaimer|DISCLAIMER]]:''' PW's [[dosage]] information is gathered from users and [[Network|resources]] for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy. | ||
|OralROA_Bioavailability= | |OralROA_Bioavailability= | ||
|OralROA_Threshold=[[Oral threshold dose:: | |OralROA_Threshold=[[Oral threshold dose::2]] - 4 [[Oral dose units::mg]] | ||
|OralROA_Light=[[Oral min light dose:: | |OralROA_Light=[[Oral min light dose::4]] - [[Oral max light dose::8]] mg | ||
|OralROA_Common=[[Oral min common dose:: | |OralROA_Common=[[Oral min common dose::8]] - [[Oral max common dose::15]] mg | ||
|OralROA_Strong=[[Oral min strong dose:: | |OralROA_Strong=[[Oral min strong dose::15]] - [[Oral max strong dose::25]] mg | ||
|OralROA_Heavy=[[Oral heavy dose:: | |OralROA_Heavy=[[Oral heavy dose::25]]+ mg<span style="color:red"> '''Heavy doses may result in psychosis and mania.'''<ref name="psychosis">3-MeO-PCP Psychosis (PsychonautWiki) | https://psychonautwiki.org/wiki/3-MeO-PCP#Toxicity_and_harm_potential</ref></span> | ||
|OralROA_TimelineFile= | |OralROA_TimelineFile= | ||
|OralROA_TimelineWidth= | |OralROA_TimelineWidth= | ||
|OralROA_Duration=[[Oral min total time:: | |OralROA_Duration=[[Oral min total time::6]] - [[Oral max total time::8]] [[Oral total time units::hours]] | ||
|OralROA_Onset=[[Oral min onset time:: | |OralROA_Onset=[[Oral min onset time::30]] - [[Oral max onset time::90]] [[Oral onset time units::minutes]] | ||
|OralROA_Peak= | |OralROA_Comeup=[[Oral min comeup time::45]] - [[Oral max comeup time::90]] [[Oral comeup time units::minutes]] | ||
|OralROA_Offset= | |OralROA_Peak=[[Oral min peak time:3]] - [[Oral max peak time::4]] [[Oral peak time units::hours]] | ||
|OralROA_Aftereffects=[[Oral min afterglow time:: | |OralROA_Offset=[[Oral min offset time::2]] - [[Oral max offset time::2]] [[Oral offset time units::minutes]] | ||
|OralROA_Aftereffects=[[Oral min afterglow time::6]] - [[Oral max afterglow time::48]] [[Oral afterglow time units::hours]] | |||
|InsufflatedROA=true | |InsufflatedROA=true | ||
Line 79: | Line 80: | ||
|InsufflatedROA_TimelineFile= | |InsufflatedROA_TimelineFile= | ||
|InsufflatedROA_TimelineWidth= | |InsufflatedROA_TimelineWidth= | ||
|InsufflatedROA_Duration=[[Insufflated min total time:: | |InsufflatedROA_Duration=[[Insufflated min total time::3]] - [[Insufflated max total time::5]] [[Insufflated total time units::hours]] | ||
|InsufflatedROA_Onset=[[Insufflated min onset time:: | |InsufflatedROA_Onset=[[Insufflated min onset time::5]] - [[Insufflated max onset time::30]] [[Insufflated onset time units::minutes]] | ||
|InsufflatedROA_Peak= | |InsufflatedROA_Comeup=[[Insufflated min comeup time::45]] - [[Insufflated max comeup time::90]] [[Insufflated comeup time units::minutes]] | ||
|InsufflatedROA_Offset= | |InsufflatedROA_Peak=[[Insufflated min peak time::1.5]] - [[Insufflated max peak time::2]] [[Insufflated peak time units::hours]] | ||
|InsufflatedROA_Aftereffects=[[Insufflated min afterglow time:: | |InsufflatedROA_Offset=[[Insufflated min offset time::45]] - [[Insufflated max offset time::60]] [[Insufflated offset time units::minutes]] | ||
|InsufflatedROA_Aftereffects=[[Insufflated min afterglow time::4]] - [[Insufflated max afterglow time::48]] [[Insufflated afterglow time units::hours]] | |||
}} | }} |
Revision as of 23:55, 10 January 2017
SubstanceBox/3-MeO-PCP | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chemical Nomenclature | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common names | 3-MeO-PCP, Methoxyphencyclidine | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Substitutive name | 3-Methoxyphencyclidine | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Systematic name | 1-[1-(3-methoxyphenyl)cyclohexyl]-piperidine | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class Membership | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Psychoactive class | Dissociative | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chemical class | Arylcyclohexylamine | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Routes of Administration | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
- ↑ 1.0 1.1 3-MeO-PCP Psychosis (PsychonautWiki) | https://psychonautwiki.org/wiki/3-MeO-PCP#Toxicity_and_harm_potential